| ICD Code | Description |
|---|---|
| C860 | Extranodal NK/T-cell lymphoma, nasal type |
| C861 | Hepatosplenic T-cell lymphoma |
| C862 | Enteropathy-type (intestinal) T-cell lymphoma |
| C863 | Subcutaneous panniculitis-like T-cell lymphoma |
| C864 | Blastic NK-cell lymphoma |
| C865 | Angioimmunoblastic T-cell lymphoma |
| C866 | Primary cutaneous CD30-positive T-cell proliferations |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C865 | Angioimmunoblastic T-cell lymphoma | 24.7 | |||||||||||||
| C864 | Blastic NK-cell lymphoma | NA | |||||||||||||
| C862 | Enteropathy-type (intestinal) T-cell lymphoma | NA | |||||||||||||
| C866 | Primary cutaneous CD30-positive T-cell proliferations | 38.24 | |||||||||||||
| C860 | Extranodal NK/T-cell lymphoma, nasal type | NA | |||||||||||||
| C861 | Hepatosplenic T-cell lymphoma | NA | |||||||||||||
| C863 | Subcutaneous panniculitis-like T-cell lymphoma | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C865 | Angioimmunoblastic T-cell lymphoma | 8.8 | 43.19 | ||||||||||||||||
| C864 | Blastic NK-cell lymphoma | 8.66 | 52.17 | ||||||||||||||||
| C866 | Primary cutaneous CD30-positive T-cell proliferations | 6.95 | 27.82 | ||||||||||||||||
| C860 | Extranodal NK/T-cell lymphoma, nasal type | 7.15 | 45.39 | ||||||||||||||||
| C862 | Enteropathy-type (intestinal) T-cell lymphoma | 9.09 | 42.31 | ||||||||||||||||
| C863 | Subcutaneous panniculitis-like T-cell lymphoma | 6.79 | 38.46 | ||||||||||||||||
| C861 | Hepatosplenic T-cell lymphoma | 10.21 | 55.0 |